204 related articles for article (PubMed ID: 37963251)
1. Cellular nucleic acid-binding protein restricts SARS-CoV-2 by regulating interferon and disrupting RNA-protein condensates.
Chen Y; Lei X; Jiang Z; Humphries F; Parsi KM; Mustone NJ; Ramos I; Mutetwa T; Fernandez-Sesma A; Maehr R; Caffrey DR; Fitzgerald KA
Proc Natl Acad Sci U S A; 2023 Nov; 120(47):e2308355120. PubMed ID: 37963251
[TBL] [Abstract][Full Text] [Related]
2. CNBP restricts SARS-CoV2 by regulating IFN and disrupting RNA-protein condensates.
Fitzgerald K; Chen Y; Lei X; Jiang Z; Humphries F; Mustone N; Ramos I; Mutetwa T; Fernandez-Sesma A
Res Sq; 2022 May; ():. PubMed ID: 35547851
[TBL] [Abstract][Full Text] [Related]
3. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
4. Cellular nucleic acid-binding protein is essential for type I interferon-mediated immunity to RNA virus infection.
Chen Y; Lei X; Jiang Z; Fitzgerald KA
Proc Natl Acad Sci U S A; 2021 Jun; 118(26):. PubMed ID: 34168080
[TBL] [Abstract][Full Text] [Related]
5. Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4).
Kaur R; Tada T; Landau NR
mBio; 2023 Aug; 14(4):e0109023. PubMed ID: 37382452
[TBL] [Abstract][Full Text] [Related]
6. Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates.
Savastano A; Ibáñez de Opakua A; Rankovic M; Zweckstetter M
Nat Commun; 2020 Nov; 11(1):6041. PubMed ID: 33247108
[TBL] [Abstract][Full Text] [Related]
7. GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein.
Zhao M; Yu Y; Sun LM; Xing JQ; Li T; Zhu Y; Wang M; Yu Y; Xue W; Xia T; Cai H; Han QY; Yin X; Li WH; Li AL; Cui J; Yuan Z; Zhang R; Zhou T; Zhang XM; Li T
Nat Commun; 2021 Apr; 12(1):2114. PubMed ID: 33837182
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans.
Nchioua R; Kmiec D; Müller JA; Conzelmann C; Groß R; Swanson CM; Neil SJD; Stenger S; Sauter D; Münch J; Sparrer KMJ; Kirchhoff F
mBio; 2020 Oct; 11(5):. PubMed ID: 33067384
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of SARS-CoV-2 replication by a ssDNA aptamer targeting the nucleocapsid protein.
Huang Y; Huang C; Chen J; Chen S; Li B; Li J; Jin Z; Zhang Q; Pan P; Du W; Liu L; Liu Z
Microbiol Spectr; 2024 Apr; 12(4):e0341023. PubMed ID: 38376366
[TBL] [Abstract][Full Text] [Related]
10. The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies.
Zhang S; Wang L; Cheng G
Mol Ther; 2022 May; 30(5):1869-1884. PubMed ID: 35176485
[TBL] [Abstract][Full Text] [Related]
11. A New Cellular Interactome of SARS-CoV-2 Nucleocapsid Protein and Its Biological Implications.
Min YQ; Huang M; Feng K; Jia Y; Sun X; Ning YJ
Mol Cell Proteomics; 2023 Jul; 22(7):100579. PubMed ID: 37211047
[TBL] [Abstract][Full Text] [Related]
12. Liquid-liquid phase separation of nucleocapsid proteins during SARS-CoV-2 and HIV-1 replication.
Chau BA; Chen V; Cochrane AW; Parent LJ; Mouland AJ
Cell Rep; 2023 Jan; 42(1):111968. PubMed ID: 36640305
[TBL] [Abstract][Full Text] [Related]
13. The SARS-CoV-2 RNA-protein interactome in infected human cells.
Schmidt N; Lareau CA; Keshishian H; Ganskih S; Schneider C; Hennig T; Melanson R; Werner S; Wei Y; Zimmer M; Ade J; Kirschner L; Zielinski S; Dölken L; Lander ES; Caliskan N; Fischer U; Vogel J; Carr SA; Bodem J; Munschauer M
Nat Microbiol; 2021 Mar; 6(3):339-353. PubMed ID: 33349665
[TBL] [Abstract][Full Text] [Related]
14. ATP and nucleic acids competitively modulate LLPS of the SARS-CoV2 nucleocapsid protein.
Dang M; Li T; Song J
Commun Biol; 2023 Jan; 6(1):80. PubMed ID: 36681763
[TBL] [Abstract][Full Text] [Related]
15. N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition.
Pan R; Kindler E; Cao L; Zhou Y; Zhang Z; Liu Q; Ebert N; Züst R; Sun Y; Gorbalenya AE; Perlman S; Thiel V; Chen Y; Guo D
mBio; 2022 Feb; 13(1):e0366221. PubMed ID: 35073761
[TBL] [Abstract][Full Text] [Related]
16. Global analysis of protein-RNA interactions in SARS-CoV-2-infected cells reveals key regulators of infection.
Kamel W; Noerenberg M; Cerikan B; Chen H; Järvelin AI; Kammoun M; Lee JY; Shuai N; Garcia-Moreno M; Andrejeva A; Deery MJ; Johnson N; Neufeldt CJ; Cortese M; Knight ML; Lilley KS; Martinez J; Davis I; Bartenschlager R; Mohammed S; Castello A
Mol Cell; 2021 Jul; 81(13):2851-2867.e7. PubMed ID: 34118193
[TBL] [Abstract][Full Text] [Related]
17. Phase-separated nucleocapsid protein of SARS-CoV-2 suppresses cGAS-DNA recognition by disrupting cGAS-G3BP1 complex.
Cai S; Zhang C; Zhuang Z; Zhang S; Ma L; Yang S; Zhou T; Wang Z; Xie W; Jin S; Zhao J; Guan X; Wu J; Cui J; Wu Y
Signal Transduct Target Ther; 2023 Apr; 8(1):170. PubMed ID: 37100798
[TBL] [Abstract][Full Text] [Related]
18. Arginine methylation of SARS-Cov-2 nucleocapsid protein regulates RNA binding, its ability to suppress stress granule formation, and viral replication.
Cai T; Yu Z; Wang Z; Liang C; Richard S
J Biol Chem; 2021 Jul; 297(1):100821. PubMed ID: 34029587
[TBL] [Abstract][Full Text] [Related]
19. Interaction of HDAC2 with SARS-CoV-2 NSP5 and IRF3 Is Not Required for NSP5-Mediated Inhibition of Type I Interferon Signaling Pathway.
Naik NG; Lee SC; Veronese BHS; Ma Z; Toth Z
Microbiol Spectr; 2022 Oct; 10(5):e0232222. PubMed ID: 36173315
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of impairment of interferon production by SARS-CoV-2.
Hoang HD; Naeli P; Alain T; Jafarnejad SM
Biochem Soc Trans; 2023 Jun; 51(3):1047-1056. PubMed ID: 37199495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
